CClinicalTrials.gg
RecruitingNCT07477886Updated Mar 19, 2026

Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer

An observational study in Hematopoietic and Lymphatic System Neoplasm and Malignant Solid Neoplasm, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Mayo Clinic · Observational

From the registry’s dates

  • Started Feb 2026; still recruiting 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
134
Ages
18 Years and older
Sex
All
01

Study summary

This study uses ambient sensing rooms to collect data from hospitalized cancer patients in order to improve safety and recovery. Being hospitalized increases the risk for delirium (acute confusion), falls, troubles sleeping, and mood changes. Ambient sensing rooms are special rooms that use technology including a video camera to watch the room, an audio recorder to listen to sounds, and a temperature sensor (thermography) to check how warm or cool the room and people are. These tools may help nurses and doctors notice problems early, give better care, and keep patients safe and comfortable.

02

Conditions studied

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm
03

In context

Lead sponsor

Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.

Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with cancer or history of cancer diagnosis admitted to ambient intelligent rooms and clinicians participating in direct patient care activities.

Inclusion criteria

  • Patients:

    • Age >= 18
    • Not receiving comfort/end-of-life care
    • Not incarcerated
    • Admitted to one of the six rooms equipped with ambient technology
    • History of cancer or has a cancer diagnosis
  • Clinicians:

    • Age >= 18
    • Participating in direct patient care activities on Eisenberg units 4-3 as an employee of Mayo Clinic

Exclusion criteria

Exclusion Criteria:

  • Patients:

    • Age \< 18 years
    • Receiving comfort or end-of-life care
    • Incarceration (prisoner status)
    • Primary language is not English
  • Clinicians:

    • Age \< 18 years
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
134 participants (estimated)

Groups and cohorts

  • Observational group I

    Patients complete a questionnaire, have ambient sensor data collected for the duration of their stay in the ambient sensing room, participate in an interview, and have their medical records reviewed on study.

    Other: Non-Interventional Study

  • Observational group II

    Clinicians participate in a focus group on study.

    Other: Non-Interventional Study

Interventions

  • OtherNon-Interventional Study

    Non-interventional study

    Also known as: Non-Interventional Observational Study, Noninterventional (Observational) Study

06

What researchers measure

Primary outcomes

  1. Complete hospital timeline

    Will develop a complete hospital timeline that integrates input from video, audio, thermography, and patient-reported symptoms. This multimodal hospital timeline will illustrate patterns of care that result from system and human interaction.

    Time frame: Up to 1 year

07

Study locations

1 of 1 sites recruiting
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
    • Clinical Trials Referral Office · Contact · mayocliniccancerstudies@mayo.edu · 855-776-0015
    • Nursing Research Study Team · Contact · 507-422-5523
    • Allyson K. Palmer, MD, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07477886
Lead sponsor
Mayo Clinic
Responsible party
Sponsor
First posted
Mar 17, 2026
Start date
Feb 10, 2026
Primary completion
Oct 31, 2027 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Mar 19, 2026

Study contacts

Clinical Trials Referral Office
Contact
mayocliniccancerstudies@mayo.edu
855-776-0015
Nursing Research Study Team
Contact
507-422-5523
Allyson K Palmer, MD, PhD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion